News & Analysis on Clinical Trial Services & Contract Research And Development
Critical Pharmaceuticals has received a £1.5m ($2.4m) award to develop its hGH nasal spray, the market for which could be sizeable as company’s attempt to differentiate in response to generic competition.
ChemDiv’s subsidiary Chemical Diversity Research Institute (CDRI), based in Moscow, Russia, will carry out development work on a range of HIV antivirals on behalf of new drugmaker Viriom.
Indian CRO Siro Clinpharma has ramped up clinical trial manufacturing capacity at its facility in Mumbai in response to growing demand from pharma and biotech firms.
Do you enjoy reading our latest headlines? Then, why not help to write them yourself by working as a freelance correspondent for Outsourcing-Pharma.com?
The US arm of packaging giant Schott has added ready-to-fill (RTF) glass syringe manufacturing capacity at its facility in Lebanon, Pennsylvania in a $14m (€9.4m) expansion designed to meet growing demand.
Henry Hussell, marketing manager at Cargill Pharma, talks about Zerose erythritol's development since it was launched at CPhI 2008.
The EC’s plan to make excipients comply with GMP is “still alive”, according to Cargill which spoke to in-PharmaTechnologist at CPhI about its Zerose erythritol product that it claims can improve compliance.
Arch Pharmalabs is continuing its push to serve innovative pharma by adding simulated moving bed (SMB) technology, becoming the first in India to offer the offer the system for plant scale API manufacture.